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Abstract
Background: Aspergillus fumigatus is a ubiquitous saprotrophic fungus and an opportunistic pathogen of humans
and animals. Humans and animals can inhale hundreds of A. fumigatus spores daily. Normally this is harmless for
humans, but in case of immunodeficiency, invasive pulmonary aspergillosis (IPA) can develop with a high mortality
rate. A. fumigatus also causes non-invasive mycoses like sino-nasal aspergillosis (SNA) in dogs.
Results: In this study we compared A. fumigatus isolates from humans with suspected IPA, dogs with SNA, and a
set of environmental isolates. Phylogenetic inference based on calmodulin (CaM) and beta-tubulin (benA) sequences
did not reveal A. fumigatus sub-groups linked to the origin of the isolates. Genotyping and microsatellite analysis
showed that each dog was infected by one A. fumigatus genotype, whereas human patients had mixed infections.
Azole resistance was determined by antifungal susceptibility testing and sequencing of the cyp51A gene. A total of 12
out of 29 human isolates and 1 out of 27 environmental isolates were azole resistant. Of the azole resistant strains, 11
human isolates showed TR34/L98H (n = 6) or TR46/Y121F/T289A (n = 5). Phenotypically, isolates from dogs were more
variable in growth speed and morphology when compared to those isolated from human and the environment.
Conclusions:
1. A. fumigatus from dogs with SNA are phenotypically very diverse in contrast to their environmental and human
counterparts.
2. Phenotypic variability can be induced during the chronic infection process in the sinus of the dogs. The basis of
this heterogeneity might be due to genomic differences and/or epigenetic variations.
3. Differences in dogs is a could be a result of within-host adaption and might be triggered by environmental factors
in the sinus, however this hypothesis still needs to be tested.
Background
Aspergillus fumigatus is a filamentous saprotrophic asco-
mycete that occurs world-wide [1]. This fungus produces
large numbers of conidia that are released into the air [2–
5]. Estimates indicate that humans can inhale a few hun-
dred of these asexual spores of A. fumigatus a day [2, 6].
Their small diameter of 2–3 μm and hydrophobic surface
enables them to reach the alveoli [7]. Yet, most of them
are trapped and removed by the mucociliary escalator or
by immune cells present in the lung tissue. Upon germin-
ation, they can cause invasive or non-invasive forms of as-
pergillosis. The former is characterised by the penetration
and infection of tissues [8]. A. fumigatus has been shown
to secrete mycotoxins like gliotoxin, verruculogen, fumagil-
lin and helvolic acid, which can affect ciliary beat frequency
and promote colonization of lung epithelium [9, 10]. Inva-
sive aspergillosis most often occurs in individuals with
impaired cell-mediated immunity [8]. Additionally this
fungus is able to cause mycosis in animals such as cats
and dogs [11]. For instance, it is responsible for most
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cases of sino-nasal aspergillosis in dogs (SNA) [12]. Ca-
nine SNA is clinicopathologically similar to chronic
erosive non-invasive fungal sinusitis in humans [13]. It
is characterized by the formation of fungal plaques (i.e.
fungal biofilms) in the nasal cavity and frontal sinus.
Other than in some invasive forms of aspergillosis in
humans [14], no evidence of impaired innate or adap-
tive immune responses have been described for dogs
suffering from SNA [15, 16]. Notably, mesocephalic
and dolichocephalic dogs seem to be affected with a
higher frequency as compared to brachycephalic dogs
for reasons that remain elusive but which could be re-
lated to a smaller sino-nasal surface area of the latter
[13]. In cats A. fumigatus is one of the causative agents
of upper respiratory aspergillosis (URTA). URTA in cats
can be divided into sino-nasal aspergillosis (SNA) and
sino-orbital aspergillosis (SOA) of which SOA is the
most common condition. SNA in cats resembles SNA
in dogs and is caused primarily by A. fumigatus but also
by Aspergillus niger. SOA, on the other hand, is most
commonly caused by Aspergillus felis sensu lato [17].
Still, these infections in humans, dogs and cats are, like
most fungal infection in mammals, relatively uncommon,
especially considering the ubiquity of A. fumigatus conidia
in the environment.
Fungal infections are treated with a range of antimycotic
compounds. The antifungal activity of azoles is based on
the binding to ergosterol synthase. Both cyp51A and
cyp51B of A. fumigatus encode for this lanosterol
14α-demethylase. Azole resistance induced mutations
have been described mainly in cyp51A [18–20]. These mu-
tations can involve tandem repeats in the promotor area
in combination with point mutations in the cyp51A gene.
Of these, the TR34/L98H [21, 22] and TR46/Y121F/T289A
[23, 24] are most frequently reported with an incidence of
up to 20% % in the Netherlands depending on the site of
isolation of the resistant strain [25]. Additionally it has
been suggested that about 10% of azole resistant strains
that does not possess a mutation of the cyp51A gene can
be explained by increased activity in ABC transporters
that helps to detoxificate the fungal cell from azoles, or
mutation in other genes like hapE [20, 26, 27].
Here we performed a comparative phenotypic and gen-
etic analysis of A. fumigatus isolates from dogs with SNA,
human patients suspected of having invasive A. fumigatus
infection from a well-defined group of high-risk patients
from the haematology ward and the intensive care unit
(ICU), and isolates from indoor and outdoor substrates.
Phylogenetic inference based on calmodulin (CaM) and
beta-tubulin (benA) sequences did not reveal A. fumigatus
sub-groups but dog isolates were more variable in growth
speed and morphology. Possibly, A. fumigatus evolves
within the dog during the infection process by mutations
and / or epigenetic variations.
Methods
Fungal isolates and culturing
A total of 87 isolates of A. fumigatus were used (Table 1;
Additional file 1: Table S1) that were derived from the
environment (n = 27), infected dogs (n = 27), and
humans (n = 29). A. fumigatus var. ellipticus type-strain
[28], A. fumigatus Af293, and A. fumigatus Af1163 were
included as reference strains. A. fumigatus isolates were
originated from 9 dogs (Canine patient CP1–8.2, Add-
itional file 1: Table S1) suffering from SNA presented at
the Faculty of Veterinary Medicine in Utrecht between
2010 and 2012. One dog (CP8) was presented twice at
the hospital due to a reinfection after 2 years (CP8.2
with isolates DTO 303-F1 and -F2, Additional file 1:
Table S1). Hospitalized canine patients suspected to suffer
from SNA were subjected to computer tomography (CT),
and endoscopic/rhinoscopic, and haematological analysis.
Clinical signs specific of SNA are unilateral or bilateral
mucopurulent nasal discharge, depigmentation of the nasal
planum, an increased airflow through the nostrils, and an
enlarged ipsilateral mandibular lymph node. In the case a
fungal plaque was detected (Additional file 1: Table S1), tis-
sue and blood samples were sent to the Veterinary Path-
ology Diagnostic Center and the Veterinary Diagnostic
Laboratory of Utrecht University. Haematocrit, leucocytes,
Table 1 Overview of A. fumigatus isolates
Number of isolates Provided by Country of origin Reference/Year
Environmental 23 Westerdijk Institute Utrecht The Netherlands and Germany 2005–2008
4 Westerdijk Institute Utrecht Ireland [4], 2005
Canine isolates 27 Clinical Sciences of Companion Animals,
Veterinary Medicine, Utrecht University
The Netherlands 2010–2012
Human isolates 29 University Medical Centre Utrecht The Netherlands [30], 2011–2013
Aspergillius fumigatus Af293
(CBS 126847)
1 Westerdijk Institute Utrecht UK [51], 1993
Aspergillius fumigatus A1163 1 Westerdijk institute Utrecht France [52], 2008
Aspergillius fumigatus var. ellipticus 1 Westerdijk Institute Utrecht USA [28], 1965
Valdes et al. BMC Microbiology  (2018) 18:118 Page 2 of 11
blood cell differentiation, total protein, albumin and the
protein spectrum was measured in the blood samples.
Fungal plaques were obtained via trephination of the
frontal sinus and/or rhinoscopic removal in the nasal
sinus with a 30 degrees 2.7 mm rigid endoscope and
using a combination of suction and a metal hook.
Trephination was performed if mycotic plaques in the
frontal sinus were diagnosed by CT. After removal of
the fungal plaques the nasal sinus was flushed in most
cases with clotrimazol for 15 min each in ventral, left
and right lateral, and dorsal recumbency, followed by
flushing for 15 min in ventral recumbency, after which
the clotrimazol was allowed to leave the nasal sinus by
gravity (head down). Part of the fungal plaque was im-
mediately frozen in liquid nitrogen and stored at − 80 °
C. Remaining material was placed on ice and used for
microbial culturing and histological analysis. Culturing
was started at the same day on potato dextrose agar
(PDA, Becton Dickinson, Le-Pont-De-Claix, France) and
care was taken to inoculate plates with different pieces
of fungal plaques of the same dog. Colonies incubated
for 2 days at 37 °C presenting macroscopical characteris-
tics of A. fumigatus were sub-cultured on PDA plates
using vegetative mycelium from the outer part of the
colony as an inoculum. Conidial suspensions were made
as described [29].
Isolates from A. fumigatus were obtained from 9
high-risk patients from the intensive care and haematol-
ogy units of the Utrecht University Medical Center
(UMCU) who were suspected to have developed invasive
aspergillosis (patients HP1–9; Additional file 1: Table
S1) but none of them had received prophylactic antifun-
gal therapy. These isolates were obtained between 2011
and 2013 from sputum, bronchoalveolar lavage, or
pleural fluid (Additional file 1: Table S1; [30]). The hu-
man isolates were provided as colonies on Malt Extract
agar (MEA) plates. In order to eliminate the possibility
of having more than one isolate per plate, colonies were
sub-cultured on PDA plates using vegetative mycelium
from the edge and the centre of the colonies as inocu-
lum. Plates were inoculated by tracing a double zigzag
pattern with a plastic inoculating loop. After incubation
at 37 °C for 3 days, plates were inspected for the pres-
ence of colonies with different morphology. Clearly dis-
tinct colonies were treated as different isolates. Conidial
suspensions were prepared as described [29].
Phenotypic characterization of fungal isolates
Phenotypic characterization was performed on creatine
sucrose agar (CREA), Czapek yeast agar (CYA), CYA
with 5% NaCl (CYAS), dichloran 18% glycerol agar
(DG18), malt extract agar (MEA), yeast extract sucrose
agar (YES) as recommended [29]. A 3-point inoculation
was used and plates were incubated lid-side up at 25 °C
for a period of 7 days in the dark. Diameter of colonies
was analysed by ImageJ [31] after taken photographs
from a fixed height with a Canon camera with a tele-
photo lens. They were subjected to PCA and k-means
clustering with k = 3 corresponding to the initial number
of groups (i.e. indoor and outdoor substrates, dog, and
human). In addition, colour of the medium underneath
the colony, spatial distribution of conidia formation, and
morphology of the conidiophores was analysed. Pictures
of conidiophores and conidia were made as described
[29]. Mycelium was scraped of colonies that had been
grown on MEA for 7 days. This mycelium was mounted
on an object glass in a drop of lactic acid and a very
small drop of ethanol (70%) was used to flush the excess
conidia outward. Samples were studied using Olympus
BH2 and Zeiss Axioskop microscopes.
DNA isolation, sequencing, genetic and phylogenetic
analysis
Genomic DNA was isolated with the UltraClean Microbial
DNA Isolation kit (MO BIO Laboratories, Solana Beach
CA) and used to PCR amplify fragments of calmodulin
(CaM), β-tubulin (benA), and the mating type loci
MAT1–1 and MAT1–2 (Table 2; [29]). Sequencing of the
reverse and forward strands was performed using the Big
Dye® Terminator Cycle Sequencing Ready Reaction kit
(Applied Biosystems, Foster City, CA, USA). Products of
the sequencing reactions were purified using Sephadex
G-50 gel filtration (GE Healthcare, Little Chalfont, Buck-
inghamshire, UK), equilibrated in double-distilled water,
Table 2 Primers and temperature conditions used for PCR [29]
Locus Primer Annealing temp (°C) Cycles Direction Sequence (5′-3′) Reference
CaM CMD5 55 35 Forward CCGAGTACAAGGARGCCTTC [53]
CMD6 55 35 Reverse CCGATRGAGGTCATRACG TGG
BenA Bt2a 55 35 Forward GGTAACCAAATCGGTGCTGTTC [54]
Bt2b 55 35 Reverse ACCCTCAGTGTAGTGACCCTTGGC
MAT1–1 AFM1_F65655
MAT1_R6215
48
48
30
30
Forward
Reverse
CCTYGACGMGATGGGITGG
TGTCAAAGARTCCAAAAGGAGG
this study
MAT1–2 MAT2_F6086
MAT2_R6580
48
48
30
30
Forward
Reverse
TCGACAAGATCAAAWCYCGTC
CTTYTTGARCTCTTCYGCTAGG
this study
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and analyzed using the ABI PRISM 310 Genetic Analyzer
(Applied Biosystems). The CaM and benA sequences of
the isolates and A. niger NRRL326, A. clavatus NRRL1, A.
felis CBS130245, A. lentulus NRRL35552, A. fumigatus
NRRL5109, A. fumigatus NRRL164, A. fumigatus NRRL163,
and N. fischeri NRRL181 were used to construct a phylo-
genetic inference. Phylogenetic trees were constructed
using the ETE Toolkit pipeline [32] and visualized with
Figtree v1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/).
Microsatellite analysis
Microsatellite genotyping was performed using the STRAf
assay as described [33]. All nine markers data were
imported into R package poppr [34] to construct a mini-
mum spanning tree. Bruvo distance was used to deter-
mine genetic diversity between isolates [35].
TR profiling and microdilution assay
TR34 and TR46 repeat analysis within cyp51A was per-
formed using qPCR as described [36], additional informa-
tion about the sequence of the cyp51A was available for
human isolates (Additional file 1: Table S1). Microdilution
assays to determine Minimum inhibitory concentrations
(MIC) of itraconazole (Santa Cruz Biotech, Dallas, USA),
posaconazole (MSD, Kenilworth, USA) and voriconazole
(Pfizer, New York, USA) were performed according to
EUCAST (http://www.eucast.org/fileadmin/src/media/PDFs/
EUCAST_files/AFST/Files/EUCAST_E_Def_9_3_Mould_
testing_definitive.pdf).
Results
Histology and haematological analysis
CT scan and rhinoscopy confirmed sinonasal mycosis in
9 dogs presented at the Veterinary hospital at Utrecht
University. Histopathological biopsies showed non-in-
vading hyphae on the mucosal surface. The lamina pro-
pria was not invaded (Additional file 2: Figure S1).
Conidiophores were rarily observed, which is consistent
with the observation that fungal plaques in the nasal
cavities were white (Additional file 2: Figure S1B). The
lamina propria was infiltrated by large amounts of lym-
phocytes, plasma cells, and neutrophil granulocytes.
Fig. 1 Minimum spanning tree of A. fumigatus isolates. Circles indicate different genotypes, numbers inside the circles indicate the number of
isolates belonging to that particular genotype, thickness of the line indicates the relatedness of the connected isolates determined by Bruvo
distance; values close to zero indicate identical isolates, while values close to 1 indicate unrelated isolates [35]. Additionally, TR mutations present
in the isolates are depicted as color-coded stars. The black star (WT) refers to azole sensitive phenotype
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Haematological analysis showed differences in the levels
of blood albumin in all dogs. Four dogs showed signs of
mild blood loss in the weeks before the treatment, which
could explain the hypoalbuminemia. Together, all 9 dogs
suffered from a chronic lymphoplasmacellular rhinitis
with fungal hyphae and ulcerations.
Genotyping and phylogeny
A phylogenetic tree of the A. fumigatus isolates was con-
structed using the benA and CaM genes (Additional file 3:
Figure S2). In 4 out of 87 isolates only one of these genes
was amplified successfully (Additional file 1: Table S1).
The tree based on CaM (Additional file 3: Figure S2)
showed no subgroups of isolates. They all grouped with A.
fumigatus Af293 and NRRL 163 (Additional file 3: Figure
S2, left) but not with the emerging fungal pathogen A. felis
[17] (Additional file 3: Figure S2). The same result was ob-
tained when the tree was constructed with benA se-
quences (Additional file 3: Figure S2, right), indicating
that these markers are unable to distinguish between the
set of isolates used in this study.
Fungal isolates from an individual dog were of the
same mating type, while both mating types were present
in individual human patients (4 out of 9). The 9 infected
dogs had either isolates with MAT1.1 (4) or MAT1.2 (5).
The fungal isolates from humans (15 isolates having
MAT1.1 and 12 isolates having MAT1.2) and indoor and
outdoor substrates (12 isolates having MAT1.1 and 13
isolates having MAT1.2) also showed a ratio close to 1.
Because of the inability of the previous markers to differ-
entiate between isolates, genetic heterogeneity was fur-
ther analyzed by microsatellite analysis using the STRAf
assay. A total of 59 A. fumigatus genotypes were found
within the 87 isolates with a genetic distance between
the isolates ranging between 0.056 and 0.496 (Fig. 1).
Most of the isolates were found to be of a unique distant
genotype. In the case of indoor and outdoor substrates
only two genotypes were represented by more than one
isolate. Similarly, most of the isolates from a human in-
dividual were of a different genotype (Fig. 2). Moreover,
genotypes were different between human individuals ex-
cept for genotype 10 (Additional file 1: Table S1) which
was found in two human patients. In contrast, the 27
dog isolates from the 9 dogs grouped only in six clusters.
The isolates derived from an individual dog all had the
same genotype (Fig. 2, Additional file 1: Table S1).
Phenotyping of A. fumigatus isolates
Most isolates showed a colony and conidiophore morph-
ology typical for A. fumigatus(Fig. 3). However, the iso-
lates from dogs were phenotypically more diverse as
compared to those from the environment or humans
(Tables 3 and 4). Variation was also observed between
isolates from a single dog. This was the case for dogs
CP1, CP2, CP4, CP7 and CP8.2. Conidiophore morph-
ology was atypical in 12 out of 27 isolates from dogs.
Fig. 2 Schematic overview of the nine human and canine patients. The total number of genotypes and the codes of the A. fumigatus isolates
from each patient is indicated. Isolates that are underlined belong to the same genotype in the case of canine patients, an asterisk indicates the
same patient (CP8 – CP8.2) being re-infected with a different A. fumigatus isolate
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Fig. 3 Morphology of colonies (a) and conidiophores and conidia (B-D) of A. fumigatus isolates from dogs, humans and the environment. Top
row of panel A shows the obverse side of the colony grown on MEA of isolates DTO 028-D6, DTO 271-A5, and DTO 303-E8, while the bottom
row shows the reverse side of CYA-grown colonies of DTO 028-D6, DTO 326-I9, DTO 326-H2. A conidiophore of DTO 327-D3 with flask-shaped
phialides and abundant production of conidia is shown in (b), while (c) shows similar phialides of isolate DTO 326-I9 with sparse production of
conidia. Reduced, cylindrical shaped phialides of DTO 303-F2 and abundant production of conidia are shown in (d)
Table 3 Number of isolates from human, dog and indoor and outdoor substrates per phenotypic trait
Phenotype Canine (27) Environmental (27) Human (29) Reference (3)
Degree of sporulation and
phialide shape in MEA
Strong sporulation and cylindrical phialides 1
Strong sporulation and flask-shaped phialides 15 27 29 3
Sparse sporulation and flask-shaped phialides 11
Dark greenish colony 14 27 29 2
Sporulation in MEA Mostly whitish colony, with the center of the
colony green followed by concentric rings of
pale yellowish green
12 1
Whitish colony with star-like green patches 1
Acid production absent 20 15 29 3
Acid production on CREA Acid production present 7 12
Brownish 1 3
Reverse color on CYA Green with brown center and white margins 1 2 1
White 26 26 24 2
Total number of isolates per source is indicated between brackets
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Furthermore, whitish colonies with concentric green
rings of conidia forming conidiophores were observed in
12 out of the 27 fungal isolates (Fig. 3). This phenotype
was associated with reduced production of conidia as
compared to the fungal isolates from human patients
and outdoor en indoor substrates. Acidification of CREA
medium was not observed in the case of human isolates
and the reference strains but was detected in 7 out of 27
fungal isolates from dogs and 12 out of 27 environmen-
tal isolates (Table 3 and Additional file 1: Table S1).
Additionally, high variation was observed in the average
diameter of colonies of isolates from dogs grown on
CREA, MEA, YES, DG18, CYAS (Table 5). PCA and
k-means clustering using colony diameter as a proxy for
growth showed that one cluster contained only 5 isolates
from dogs (DTO 303-E6, DTO 303-F5, DTO 303-E5,
DTO 271-B3, DTO 271-B2) as well as A. fumigatus var.
ellipticus (cluster 1 in Fig. 4) The isolates from indoor
and outdoor substrates and human patients were distrib-
uted in clusters 2 and 3. Fourteen and eight isolates
from dogs clustered in clusters 2 and 3, respectively
(Fig. 4).
TR profiling and resistance to azoles
Microdilution assays showed that 12 out of the 29 hu-
man isolates were resistant to itraconazole, posaconazole
and/or voriconazole. Of these isolates, 6 showed a TR34
promotor duplication in cyp51A and 5 a TR46 duplica-
tion in this gene. One resistant (DTO 060-G9) and 3
intermediate resistant (DTO 028-D6, DTO 086-C1,
DTO 089-G1) posaconazole strains were identified in
the environmental isolates from the Netherlands. Dog
isolates were all sensitive to the azoles tested, and both
groups of strains (Dog and environmental) did not show
TR34 and TR46 mutations. The Af293 strain was sensi-
tive to itraconazole and posaconazole and resistant to
voriconazole like the results presented by Mowat et al.
[37] (Additional file 1: Table S1) and the EUCAST MIC
distribution for Af293 (Additional file 4: Figure S3)
Af293 is however generally considered susceptible for
this azole.
Discussion
We assessed phenotypic and genetic differences between
strains of A. fumigatus isolated from indoor and outdoor
substrates and from infected humans and dogs. Genetic
analyses did not indicate the existence of sub-groups
within A. fumigatus specialized in infecting human or
dog. A notable variation in phialide morphology, sporu-
lation, colony size, and colony color was observed be-
tween strains isolated from dogs suffering from SNA;
even between isolates from the same infected individual.
This phenotypic variability was not associated with gen-
etic differences in the benA, CaM, MAT1–1, MAT1–2,
Table 4 Distribution of phenotypes of A. fumigatus isolated from 9 dogs suffering from SNA
Phenotype CP1 (6) CP2(4) CP3(3) CP4 (2) CP5(1) CP6(3) CP7(3) CP8(3) CP8.2(2)
Degree of sporulation and
phialide shape in MEA
Strong sporulation and cylindrical phialides 1
Strong sporulation and flask-shaped phialides 1 1 3 2 1 3 3 1
Sparse sporulation and flask-shaped phialides 5 3 3
Sporulation in MEA Dark greenish colony 1 1 3 1 1 3 2 2
Mostly whitish colony, with the centre of the
colony green followed by concentric rings of
pale yellowish green
5 3 1 3
Whitish colony with star-like green patches 1
Pigmentation in CREA No pigment 5 4 2 1 3 3 2
Yellow pigment 1 3 3
Pigmentation in CYA Brownish reverse 1
White reverse 6 3 3 2 1 3 3 3 2
The total number of isolates per dog is between brackets
Table 5 Mean diameter with standard deviation of colonies (mm) on each medium for each investigated isolate set
Medium Dog isolates Environmental isolates Human isolates References
CREA 31.81 ± 10.52 26.73 ± 6.90 29.55 ± 7.98 25.31 ± 12.02
CYA 36.90 ± 11.25 44.57 ± 4.62 42.44 ± 4.32 39.98 ± 10.96
CYAS 28.66 ± 10.76 25.54 ± 3.53 24.83 ± 6.81 14.74 ± 11.30
DG18 28.65 ± 9.99 19.92 ± 2.85 28.67 ± 8.76 11.56 ± 11.86
MEA 36.37 ± 11.04 44.55 ± 5.96 45.63 ± 3.87 39.06 ± 11.22
YES 38.98 ± 11.90 49.02 ± 3.20 47.36 ± 5.72 41.78 ± 13.26
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cyp51A loci and microsatellites. This indicates that the
dogs were infected with a single strain. It is tempting to
speculate that the phenotypic differences evolve within
the dog during the infection process due to epigenetic
changes or mutations. The fact that phenotypic variabil-
ity was hardly observed in isolates from human and
from indoor and outdoor substrates suggests that the
dog sinus induces phenotypic evolution. SNA in dogs is
a chronic infection starting with an inoculum in the
front of the sinus [13]. This may be the cause of the ob-
served variation in the dog isolates. A long exposure to a
stressful environment and for example host immune re-
sponse, nutrient, and gas (oxygen) availability may act as
a selection pressure [36]. Reduced asexual reproduction,
as observed in 11 out of 27 dog isolates can be an adap-
tation to increase fitness in the host [38, 39]. Similarly,
higher growth rate at 37 °C have been correlated with
increased virulence [40]. Notably, in our study isolates
from dog and humans had a higher growth rate on
DG18 media as compared to the environmental isolates.
The real meaning of this variation of growth for viru-
lence is unclear and requires further investigation.
The observation that a single genotype persist in a dog
could suggest that the spread of the fungus in the sinus
proceeds gradually associated with a non-sporulating
biofilm but not invading the epithelium of the sinus
[41]. The infection within human patients is also
different from dogs because human patients can carry
multiple A. fumigatus strains [42–44]. This was con-
firmed in our study by the presence of MAT1–1 and
MAT1–2 strains isolated from an individual patient that
had different microsatellite profiles. It should be noted
that it is difficult to associate the human isolates with a
proven infection since they were obtained via bronchoal-
veolar lavage or sputum samples and not from deep tis-
sue samples.
Clinical azole resistance in the Netherlands is 5–20%
for A. fumigatus isolated from human patients [25, 30,
45]. The majority (89%) contain TR34/L98H or TR46/
Y121F/T289A mutations, while 11% of the resistant iso-
lates carry wild type cyp51A [46]. In our study, tandem
repeats TR34 or TR46 were only detected in human clin-
ical isolates. A single posaconazole resistant isolate from
environmental isolates was found which was not TR as-
sociated and future genome sequencing should illumin-
ate the resistance mechanism involved. Jensen and
colleagues [47] found few azole resistant environmental
isolates (4/133) in the National Mycology Reference La-
boratory of Denmark. In contrast, Klaassen et al. [48] re-
ported that 16 out of the 213 clinical isolates and 9 of
the 42 environmental isolates contained the TR34/L98H
allele associated with multi-triazole-resistance. Clearly,
extensive azole fungicide use in the environment can re-
sult in selection of azole resistant strains and complicate
Fig. 4 PCA and K-means clustering of A. fumigatus isolates based on colony grown on several media. The arrow indicates the position of A.
fumigatus var. ellipticus
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clinical management [49]. A survey including whole gen-
ome sequencing (WGS) between environmental and
clinical isolates can give clues about the evolution of re-
sistance in both niches [50].
Conclusion
Taken together our results showed that phenotypic and
genetic heterogenicity is a key factor to understand sev-
eral aspects of infections caused by A.fumigatus. Dog
SNA isolates were phenotypically more diverse than hu-
man and environmental isolates. Additionally, using the
STRAf assay we observed that fungal plaques from dog
suffering SNA harbour isolates genetically identical (one
genotype), while humans with suspected IPA are in-
fected with multiple genotypes. Phenotypic variation in
dog isolates might be due to genomic differences or epi-
genetic variations and due to host adaption during the
chronic infection process in dogs. New experiments aim-
ing to understand the genomic, epigenetic and physio-
logical adaptations of the isolates studied can provide
clues host-driven evolution and its implication in viru-
lence and control of the disease caused by this pathogen
in humans.
Additional file
Additional file 1: Table S1. Excel file with detailed phenotypic and
genetic data .n.d, not determined (no PCR product or sequence obtained)
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Additional file 2: Figure S1. Histology section of the mucosa of a dog
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nasalis (B). Arrow in (A) indicates mucosa tissue with high infiltration of
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Additional file 3: Figure S2. Phylogenetic inference constructed using
CaM (left) and benA (right) sequences of human, dog, and indoor and
outdoor isolates as well as reference strains. Green represents indoor and
outdoor isolates, blue and red represent isolates from dogs and human,
respectively, and black represents reference strains. A.felis indicated with
*. (TIF 2808 kb)
Additional file 4: Figure S3. Voriconazole MIC distribution for
Microdilution assay from EUCAST (consulted 22/06/2018), note that MIC of
4 mg/L are reported. (JPG 108 kb)
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